Zions Therapeutics
Research and treatment development for Endophthalmitis.
Based in UT
AI Overview
With $95K in lobbying spend across 25 quarterly filings, Zions Therapeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $95K |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Zions Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
FDA reviews for approvals from cataract therapies; CMS coverage determinations for alternative therapies to current treatment regimens for cataract surgeries.
Seeking report language on reimbursement for safer cataract procedure.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.